Latest news with #MSSH
&w=3840&q=100)
Business Standard
20-05-2025
- Business
- Business Standard
Max Healthcare Q4 results: Profit rises 27% at ₹319 cr, dividend declared
Max Healthcare on Tuesday announced a consolidated net profit of ₹319 crore for the quarter ended March 31, 2025 (Q4 FY25), marking a 26.8 per cent increase compared to ₹251.54 crore reported in the same quarter last year (Q4 FY24). Sequentially, the profit rose 33.6 per cent from ₹238.8 crore recorded in Q3 FY25. The company's consolidated revenue from operations stood at ₹1,956.86 crore in Q4 FY25, up 33.4 per cent from ₹1,467.02 crore in Q4 FY24. On a sequential basis, revenue rose 2.9 per cent from ₹1,901.51 crore in Q3 FY25. 'We are proud to report the 18th consecutive quarter of year-on-year growth in both Revenue and Operating EBITDA — a testament to the strength of our operating model, the trust of our patients, and the relentless efforts of our teams,' said Abhay Soi, chairman and MD, Max Healthcare Institute Ltd. 'We also took significant strategic steps in Q4 to position the company for long-term growth, including corporate actions and two M&A transactions. Notably, we completed the acquisition of land adjoining MSSH, Vaishali, paving the way for a brownfield expansion in this very busy hospital. As we look ahead, we are excited about commencing the operations at our three new brownfield towers in Saket, Nanavati and Mohali hospitals in the next three months and adding 1,500 beds to the capacity in the current financial year, which will further reinforce our leadership in quality healthcare delivery across geographies that we operate in,' Soi said. Max Healthcare FY25 results For the entire year, Max Healthcare reported a consolidated net profit of ₹1,075.88 crore, marking a modest increase from ₹1,057.64 crore in FY24. Meanwhile, the company's revenue from operations for FY25 rose significantly to ₹7,028.46 crore, up 30 per cent from ₹5,406.02 crore in the previous fiscal year. Dividend announced Meanwhile, the board of directors of the company recommended a dividend of ₹1.5 per share for the financial year 2024-25, subject to the approval of shareholders. Shares of Max Healthcare were last traded at ₹1165.30 apiece on the BSE at the closing of the market. Max Healthcare Q4 highlights Profit: ₹319 crore Revenue: ₹1,956.86 crore EPS: ₹3.28 (basic), ₹3.26 (diluted) Max Healthcare FY highlights: Profit: ₹1,075.88 crore Revenue: ₹7,028.46 crore EPS: ₹11.07 (basic), ₹11.01 (diluted)
Time of India
20-05-2025
- Business
- Time of India
Max Healthcare Q4 Results: Revenue rises 29%, PAT at Rs 376 crore
Max Healthcare Institute Ltd (MHIL) on Tuesday reported network gross revenue at Rs 2,429 crore in the fourth quarter ended March, up 29% from a year ago. The share of revenue from new units stood at 15% compared to 2% in Q4 FY24, the company said in a press release. Profit after tax (PAT) for the quarter stood at Rs 376 crores compared to Rs 311 crore in Q4 FY24. Network operating EBITDA was Rs 632 crore, reflecting a growth of 26% YoY and 2% QoQ. EBITDA margin for the network stood at 27.2% compared to 28.0% in Q4 FY24 and 27.3% in Q3 FY25. Excluding Max Dwarka – a 303 bedded greenfield hospital which started its operations in July 2024, the EBITDA margin was 28.1% Overall EBITDA per bed was Rs 73.9 lakhs compared to Rs 76.0 lakhs in Q4 FY24. Excluding Max Dwarka, which is in its third quarter of operations, EBITDA per bed stood at Rs 77.6 lakhs. Live Events 'We took significant strategic steps in Q4 to position the company for long-term growth, including corporate actions and two M&A transactions,' said Abhay Soi, Chairman and Managing Director, Max Healthcare Institute Ltd. 'We completed the acquisition of land adjoining MSSH, Vaishali, paving the way for a brownfield expansion in this very busy hospital. As we look ahead, we are excited about commencing the operations at our three new brownfield towers in Saket, Nanavati and Mohali hospitals in the next three months and adding 1,500 beds to the capacity in the current financial year, which will further reinforce our leadership in quality healthcare delivery across geographies that we operate in,' he added. In March, the company executed a long-term service agreement with the Bharat Prakritik Chikitsa Mission for the establishment of a 200 beds hospital in Pitampura in Delhi. The upcoming facility will provide tertiary care services, including radiation oncology and organ transplantation. Construction of the hospital is expected to be completed within the next 3 to 4 years. In May, Max Super Specialty Hospital, Vaishali (MSSH, Vaishali) executed a sale deed for the purchase of a land parcel of one acre, along with the building thereon. The property adjoins the existing hospital premises and will enable brownfield expansion of the hospital's capacity from 387 beds to 527 beds, within the next 30 months. For the year ended March, the company's network gross revenue stood at Rs 9,065 Cr representing a growth of 26% over the corresponding period last fiscal.
